Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if IRWD is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
32 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
212 filers reported a long position in IRWD for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $74.9M | 17.8M | +33.1% |
| ARMISTICE CAPITAL, LLC | $58.7M | 13.9M | -7.3% |
| Sarissa Capital Management LP | $38.7M | 9.2M | Unchanged |
| STATE STREET CORP | $37.1M | 8.8M | +18.1% |
| BANK OF AMERICA CORP /DE/ | $36.6M | 8.7M | 0% |
| RENAISSANCE TECHNOLOGIES LLC | $33.7M | 8M | -0.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | $27.8M | 6.6M | +8.4% |
| AQR CAPITAL MANAGEMENT LLC | $27.2M | 6.5M | -14.2% |
| ACADIAN ASSET MANAGEMENT LLC | $24.6M | 5.9M | -11% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $23.2M | 5.5M | -17.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.